These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29876772)

  • 1. Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey.
    Stargardt T; Eckmann C; Bouza E; Rossolini GM; Grossi PA
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1611-1618. PubMed ID: 29876772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital.
    Pollack CV; Amin A; Ford WT; Finley R; Kaye KS; Nguyen HH; Rybak MJ; Talan D
    J Emerg Med; 2015 Apr; 48(4):508-19. PubMed ID: 25605319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines.
    Moran GJ; Abrahamian FM; Lovecchio F; Talan DA
    J Emerg Med; 2013 Jun; 44(6):e397-412. PubMed ID: 23466022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.
    Russo A; Concia E; Cristini F; De Rosa FG; Esposito S; Menichetti F; Petrosillo N; Tumbarello M; Venditti M; Viale P; Viscoli C; Bassetti M
    Clin Microbiol Infect; 2016 Apr; 22 Suppl 2():S27-36. PubMed ID: 27125562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V; Khachatryan A; Xue M; Dunne M; Johnson K; Stephens J
    J Med Econ; 2015; 18(12):1092-101. PubMed ID: 26368787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department.
    Almarzoky Abuhussain SS; Burak MA; Kohman KN; Jacknin G; Tart SB; Hobbs ALV; Adams DK; Nailor MD; Keyloun KR; Nicolau DP; Kuti JL
    BMC Health Serv Res; 2018 Dec; 18(1):932. PubMed ID: 30514295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial stewardship in patients with acute bacterial skin and skin-structure infections: An international Delphi consensus.
    Soriano A; Stefani S; Pletz MW; Menichetti F;
    J Glob Antimicrob Resist; 2020 Sep; 22():296-301. PubMed ID: 32068092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non-Lower-Extremity Infections
    Joseph WS; Culshaw D; Anuskiewicz S; De Anda C; Prokocimer P
    J Am Podiatr Med Assoc; 2017 Jul; 107(4):264-271. PubMed ID: 27533787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bacterial skin infections in ED observation units: factors influencing prescribing practice.
    Haran JP; Wu G; Bucci V; Fischer A; Boyer EW; Hibberd PL
    Am J Emerg Med; 2015 Dec; 33(12):1780-5. PubMed ID: 26381681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment.
    Lane S; Johnston K; Sulham KA; Syed I; Pollack CV; Holland T; Nathwani D
    Clin Ther; 2016 Mar; 38(3):531-44; quiz 544.e1-9. PubMed ID: 26874786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
    Amara S; Adamson RT; Lew I; Huang X
    Curr Med Res Opin; 2013 Jul; 29(7):869-77. PubMed ID: 23659559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dalbavancin: A Review in Acute Bacterial Skin and Skin Structure Infections.
    Scott LJ
    Drugs; 2015 Jul; 75(11):1281-91. PubMed ID: 26105117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections.
    Pasquale TR; Trienski TL; Olexia DE; Myers JP; Tan MJ; Leung AK; Poblete JE; File TM
    Am J Health Syst Pharm; 2014 Jul; 71(13):1136-9. PubMed ID: 24939504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oritavancin, a single-dose, complete regimen, for the treatment of acute bacterial skin and skin structure infections.
    Wu G; Truong J; Lee S; Elnadoury O; Kuan W; Abraham T; Wu A; Liu M
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):409-16. PubMed ID: 25661747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of new-generation antibiotics in acute bacterial skin and skin structure infections.
    Giacobbe DR; Labate L; Vena A; Bassetti M
    Curr Opin Infect Dis; 2021 Apr; 34(2):109-117. PubMed ID: 33395093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective.
    Huang X; Beresford E; Lodise T; Friedland HD
    Am J Health Syst Pharm; 2013 Jun; 70(12):1057-64. PubMed ID: 23719884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections.
    Turco NJ; Kane-Gill SL; Hernandez I; Oleksiuk LM; D'Amico F; Pickering AJ
    Expert Opin Pharmacother; 2018 Mar; 19(4):319-325. PubMed ID: 29509504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging drugs for acute bacterial skin and skin structure infections: an update.
    Kollipara R; Downing C; Lee M; Guidry J; Curtis S; Tyring S
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):431-40. PubMed ID: 25146459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing practices and attitudes toward giving children antibiotics.
    Paluck E; Katzenstein D; Frankish CJ; Herbert CP; Milner R; Speert D; Chambers K
    Can Fam Physician; 2001 Mar; 47():521-7. PubMed ID: 11281085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' attitudes to the pharmacological treatment of patients with stable angina pectoris.
    Beaulieu MD; Brophy J; Jacques A; Blais R; Battista RN; Lebeau R
    QJM; 2005 Jan; 98(1):41-51. PubMed ID: 15625353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.